{"transactions":[{"id":4624838,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":62164,"kind":"person","name":"Savage Brian","position":1,"cik":"0002112339","reported_name":"Savage Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Legal Officer"}}],"security":"Stock Options (right to buy)","published_at":"2026-09-22T21:01:52.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":false,"shares":4503,"price":34.7,"value":156254.1,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options were granted on March 3, 2017, with 1,125 vested on each of March 3, 2018, March 3, 2019 and March 3, 2020, and 1,128 vested on March 3, 2021."}],"balance_after":0,"derivative":{"exercise_price":34.7,"expiration_date":"2027-03-03","underlying":"Ordinary Shares","underlying_shares":4503},"source":{"system":"sec-edgar","filing":"0001193125-26-398105","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2112339/000119312526398105/ownership.xml","form_type":"4"}},{"id":4624837,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":62164,"kind":"person","name":"Savage Brian","position":1,"cik":"0002112339","reported_name":"Savage Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2026-09-22T21:01:52.000Z","date":"2026-09-18","kind":"sale","planned":false,"acquired":false,"shares":314,"price":38.7038,"value":12152.9932,"ownership":{"direct":true},"balance_after":8500,"source":{"system":"sec-edgar","filing":"0001193125-26-398105","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2112339/000119312526398105/ownership.xml","form_type":"4"}},{"id":4624836,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":62164,"kind":"person","name":"Savage Brian","position":1,"cik":"0002112339","reported_name":"Savage Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2026-09-22T21:01:52.000Z","date":"2026-09-18","kind":"sale","planned":false,"acquired":false,"shares":2525,"price":39.145,"value":98841.125,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.14 to $39.155, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":8814,"source":{"system":"sec-edgar","filing":"0001193125-26-398105","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2112339/000119312526398105/ownership.xml","form_type":"4"}},{"id":4624835,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":62164,"kind":"person","name":"Savage Brian","position":1,"cik":"0002112339","reported_name":"Savage Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2026-09-22T21:01:52.000Z","date":"2026-09-18","kind":"sale","planned":false,"acquired":false,"shares":4503,"price":38.69,"value":174221.07,"ownership":{"direct":true},"balance_after":11339,"source":{"system":"sec-edgar","filing":"0001193125-26-398105","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2112339/000119312526398105/ownership.xml","form_type":"4"}},{"id":4624834,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":62164,"kind":"person","name":"Savage Brian","position":1,"cik":"0002112339","reported_name":"Savage Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2026-09-22T21:01:52.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":true,"shares":4503,"price":34.7,"value":156254.1,"ownership":{"direct":true},"balance_after":15842,"source":{"system":"sec-edgar","filing":"0001193125-26-398105","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2112339/000119312526398105/ownership.xml","form_type":"4"}},{"id":854910,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":62164,"kind":"person","name":"Savage Brian","position":1,"cik":"0002112339","reported_name":"Savage Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2026-03-09T20:09:13.000Z","date":"2026-03-05","kind":"exercise","planned":false,"acquired":false,"shares":3580,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on March 5, 2025, with 3,580 vested on March 5, 2026, and 3,580 vesting on each of March 5, 2027, March 7, 2028 and March 5, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on March 5, 2025, with 3,580 vested on March 5, 2026, and 3,580 vesting on each of March 5, 2027, March 7, 2028 and March 5, 2029."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":10740,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3580},"source":{"system":"sec-edgar","filing":"0001193125-26-098501","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098501/ownership.xml","form_type":"4"}},{"id":854909,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":62164,"kind":"person","name":"Savage Brian","position":1,"cik":"0002112339","reported_name":"Savage Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-09T20:09:13.000Z","date":"2026-03-05","kind":"sale","planned":false,"acquired":false,"shares":1127,"price":31.6684,"value":35690.2868,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.26 to $32.34, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":10914,"source":{"system":"sec-edgar","filing":"0001193125-26-098501","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098501/ownership.xml","form_type":"4"}},{"id":854908,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":62164,"kind":"person","name":"Savage Brian","position":1,"cik":"0002112339","reported_name":"Savage Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-09T20:09:13.000Z","date":"2026-03-05","kind":"exercise","planned":false,"acquired":true,"shares":3580,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":12041,"source":{"system":"sec-edgar","filing":"0001193125-26-098501","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098501/ownership.xml","form_type":"4"}},{"id":857136,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":62164,"kind":"person","name":"Savage Brian","position":1,"cik":"0002112339","reported_name":"Savage Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2026-03-06T21:03:56.000Z","date":"2026-03-04","kind":"grant","planned":false,"acquired":true,"shares":11280,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Restricted share units were granted on March 4, 2026, with 2,820 vesting on each of March 4, 2027, March 4, 2028, March 4, 2029 and March 4, 2030."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Restricted share units were granted on March 4, 2026, with 2,820 vesting on each of March 4, 2027, March 4, 2028, March 4, 2029 and March 4, 2030."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":11280,"derivative":{"underlying":"Ordinary Shares","underlying_shares":11280},"source":{"system":"sec-edgar","filing":"0001193125-26-096477","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526096477/ownership.xml","form_type":"4"}},{"id":857135,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":62164,"kind":"person","name":"Savage Brian","position":1,"cik":"0002112339","reported_name":"Savage Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2026-03-06T21:03:56.000Z","date":"2026-03-04","kind":"exercise","planned":false,"acquired":false,"shares":3766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 4, 2024, with 3,766 vested on each of March 4, 2025 and March 4, 2026, 3,766 vesting on March 4, 2027, and 3,768 vesting on March 4, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 4, 2024, with 3,766 vested on each of March 4, 2025 and March 4, 2026, 3,766 vesting on March 4, 2027, and 3,768 vesting on March 4, 2028."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":7534,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3766},"source":{"system":"sec-edgar","filing":"0001193125-26-096477","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526096477/ownership.xml","form_type":"4"}},{"id":857134,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":62164,"kind":"person","name":"Savage Brian","position":1,"cik":"0002112339","reported_name":"Savage Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2026-03-06T21:03:56.000Z","date":"2026-03-04","kind":"exercise","planned":false,"acquired":false,"shares":4744,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on March 4, 2022, with 4,741 vested on each of March 4, 2023, March 4, 2024 and March 4, 2025, and 4,744 vested on March 4, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on March 4, 2022, with 4,741 vested on each of March 4, 2023, March 4, 2024 and March 4, 2025, and 4,744 vested on March 4, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4744},"source":{"system":"sec-edgar","filing":"0001193125-26-096477","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526096477/ownership.xml","form_type":"4"}},{"id":857133,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":62164,"kind":"person","name":"Savage Brian","position":1,"cik":"0002112339","reported_name":"Savage Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-06T21:03:56.000Z","date":"2026-03-04","kind":"sale","planned":false,"acquired":false,"shares":1186,"price":32.4645,"value":38502.897,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.095 to $33.30, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":8461,"source":{"system":"sec-edgar","filing":"0001193125-26-096477","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526096477/ownership.xml","form_type":"4"}},{"id":857132,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":62164,"kind":"person","name":"Savage Brian","position":1,"cik":"0002112339","reported_name":"Savage Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-06T21:03:56.000Z","date":"2026-03-04","kind":"exercise","planned":false,"acquired":true,"shares":3466,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":9647,"source":{"system":"sec-edgar","filing":"0001193125-26-096477","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526096477/ownership.xml","form_type":"4"}},{"id":857131,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":62164,"kind":"person","name":"Savage Brian","position":1,"cik":"0002112339","reported_name":"Savage Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-06T21:03:56.000Z","date":"2026-03-04","kind":"sale","planned":false,"acquired":false,"shares":1489,"price":32.4645,"value":48339.6405,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.095 to $33.30, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":6181,"source":{"system":"sec-edgar","filing":"0001193125-26-096477","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526096477/ownership.xml","form_type":"4"}},{"id":857130,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":62164,"kind":"person","name":"Savage Brian","position":1,"cik":"0002112339","reported_name":"Savage Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-06T21:03:56.000Z","date":"2026-03-04","kind":"exercise","planned":false,"acquired":true,"shares":4744,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":7670,"source":{"system":"sec-edgar","filing":"0001193125-26-096477","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526096477/ownership.xml","form_type":"4"}},{"id":859917,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":62164,"kind":"person","name":"Savage Brian","position":1,"cik":"0002112339","reported_name":"Savage Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2026-03-05T21:06:43.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":3461,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on March 3, 2023, with 3,461 vested on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 3,461 vesting on March 3, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on March 3, 2023, with 3,461 vested on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 3,461 vesting on March 3, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":3461,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3461},"source":{"system":"sec-edgar","filing":"0001193125-26-093930","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526093930/ownership.xml","form_type":"4"}},{"id":859916,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":62164,"kind":"person","name":"Savage Brian","position":1,"cik":"0002112339","reported_name":"Savage Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-05T21:06:43.000Z","date":"2026-03-03","kind":"sale","planned":false,"acquired":false,"shares":1274,"price":32.3599,"value":41226.5126,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.72 to $32.865, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":2926,"source":{"system":"sec-edgar","filing":"0001193125-26-093930","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526093930/ownership.xml","form_type":"4"}},{"id":859915,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":62164,"kind":"person","name":"Savage Brian","position":1,"cik":"0002112339","reported_name":"Savage Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-05T21:06:43.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":3461,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":4200,"source":{"system":"sec-edgar","filing":"0001193125-26-093930","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526093930/ownership.xml","form_type":"4"}}]}